AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Plague Vaccine or Diagnostics
Technology Benefits
A vaccine developed with this technology will target a surface protein required for the virulence of Yersinia pestis and is non-pathogenic
Technology Application
Vaccine development against plague; adjuvant to enhance immunogenicity in a vaccine; detection and diagnosis of plague infection
Detailed Technology Description
This patented technology exploits one of the proteins composing the pathogenic structure of Yersinia pestis. The recombinant protein or its derivatives can be used as an antigen to develop a novel vaccine for immunization against the plague.
Country/Region
USA
For more information, please click Here
